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Abstract.  The expression of the apolipoprotein A-I 
(apo A-I) gene was investigated in the myelinating 
sciatic nerve.  Hybridization analysis with an apo A-I 
cDNA probe obtained from a cDNA library of mRNA 
isolated from rapidly myelinating chick sciatic nerve 
indicated that apo A-I coding transcripts  increase dur- 
ing  development in the chick sciatic nerve in parallel 
with the increase of myelin lamellae.  Substantial  apo 
A-I-like immunoreactivity in chick sciatic nerve 
homogenates was detected by Western blotting.  The 
amount of antigen  increased from the  15-d embryonic 
stage to  1 d posthatch and then decreased.  Two sub- 
cellular fractions corresponding to the cytoplasmic 
compartments were particularly enriched  in apo A-I. 
apo A-I immunoreactivity  was also found in highly 
purified myelin preparations.  Immunohistochemical 
staining  provided further evidence for the presence of 
apo A-I in the endoneurial  compartment of the sciatic 
nerve.  Electron microscopic examination  of these frac- 
tions after negative staining  showed the presence of 
spherical and disc-shaped particles  resembling high 
density lipoproteins.  The presence of apo A-I, choles- 
terol esters, phospholipids,  and triacylglycerols in 
ultracentrifugal  fractions corresponding to serum lipo- 
proteins and the behavior of apo A-I on nondenaturing 
gradient gels implied that apo A-I was associated with 
lipid.  Studies with short-term organ cultures of sciatic 
nerves from  1-d chicks strengthened the evidence for 
local synthesis and secretion of apo A-I and apo 
A-l-containing  lipoproteins by this tissue.  These 
results establish that the apo A-I gene is actively ex- 
pressed in developing sciatic nerve during the period 
of rapid myelination.  These findings support the hy- 
pothesis that apo A-I synthesized within the nerve par- 
ticipates in the local transport of lipids used in myelin 
biosynthesis. 
T 
HE myelin  sheath  of the peripheral  nervous  system 
(PNS) ~ is  a  vastly  extended  and  modified  plasma 
membrane of the Schwann cell  (Geren,  1954).  This 
membrane is wrapped around the nerve axon in a spiral fash- 
ion to form a  tightly  compacted,  multilamellar  structure. 
During development, Schwann cells accumulate along axons 
of growing peripheral  nerves and proliferate  until they com- 
pletely engulf the axons (Speidel, 1964).  Myelinogenesis  is 
dependent  on  appropriate  interactions  of Schwann  cells, 
axons,  and extracellular  matrix  (Bunge,  1987). Apart from 
certain  lipid precursors that may be obtained partially  from 
the  circulation  or through  axoplasmic  transport  from the 
neurons,  the general consensus is that almost all myelin syn- 
thesis  and assembly is carried out within  the Schwann cell 
(Norton and Cammer, 1984). However, it is the nature of the 
axon that determines whether or not a given cell will produce 
1. Abbreviations usedin thispaper: apo A-I, apolipoprotein A-l; HDL, high 
density lipoprotein; LDL, low density lipoprotein; PNS, peripheral nervous 
system; S-2, supernatant 2; SO, supernatant of osmotically shocked myelin; 
VLDL,  very low density lipoprotein. 
myelin (Weinberg and Spencer,  1976; Bray et al., 1981). Lit- 
tie is known about the molecular details of the initiation,  as- 
sembly, and maintenance  of the myelin sheath. 
The myelin membrane is composed of 70-80% lipids and 
20-30% proteins. It has a relatively simple protein composi- 
tion;  a few proteins  account for most of the total (Lees and 
Brostoff,  1984). The major proteins  of the PNS myelin are 
PO and the basic proteins P1 and P2. On SDS-PAGE, the PO 
protein migrates at ,~28-30 kD and constitutes ~50% of the 
total myelin protein.  The polypeptide exhibits microhetero- 
geneity caused by posttranslational  glycosylation,  acylation, 
sulfation, and phosphorylation and is induced specifically as 
a consequence of the interaction  between Schwann cells and 
the myelinated type of axon (Brockes et al.,  1981). Various 
morphological,  physicochemical,  and  recent  biochemical 
approaches (Lees and Brostoff, 1984; Kirschner et al., 1984; 
Lemke and Axel,  1985) indicate that the PO protein is an in- 
tegral membrane protein of the PNS myelin.  Recent experi- 
ments from our laboratory have demonstrated that the con- 
centration  of PO protein triples between day  16 and  18 of 
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This confirmed previous investigations by Uyemura et al. 
(1979): the ontogeny of PO protein parallels myelin deposi- 
tion in the peripheral nerve and indicates the period of active 
myelination in the chick sciatic nerve is between the  14-d 
embryonic stage and ~5 d posthatch. As part of a long range 
investigation on myelination of the PNS,  we prepared and 
screened a Xgt 11 expression library of rapidly myelinating 
chick sciatic nerve in an attempt to obtain eDNA clones en- 
coding the chick PO sequence. From this preparation several 
cDNA clones were isolated, which, upon sequencing, ex- 
hibited  100%  identity to the 3' coding and noncoding se- 
quences of the chick apolipoprotein A-I (apo A-I) sequence 
recently reported by Rajavashisth et al.  (1987).  This unex- 
pected, but nevertheless intriguing, result suggested that apo 
A-I might play a critical, hitherto unsuspected, role in the 
myelinogenesis of chick peripheral nerve. 
Lipoproteins are specialized macromolecular complexes 
that serve as transporters of various lipids within the hydro- 
philic intra- or extracellular milieu (for review see Dolphin, 
1985).  apo A-I is the major protein component of plasma 
high density lipoprotein (HDL) in most animal species (Scanu 
et al.,  1982).  The polypeptide is synthesized in a variety of 
chicken tissues (Blue et al., 1982). Recently, three laborato- 
ries independently reported the isolation and characteriza- 
tion of full-length eDNA clones of chick apo A-I (Rajava- 
shisth et al., 1987; Byrnes et al., 1987; Ferrari et al., 1987). 
The amino acid sequence deduced from the nucleotide se- 
quence of these clones indicated that the chick protein is par- 
tially homologous to  mammalian apo A-I and contains a 
number of tandem repeats of 11 and 22 residues. It has been 
suggested that these repeats can assume a  largely amphi- 
pathic c~-helical structure which might mediate binding to 
lipid molecules (Segrest et al.,  1974). When the chick apo 
A-I cDNA clones were used as probes, apo A-I mRNA was 
detected in a variety of avian tissues, including liver, intes- 
tine, kidney, spleen, breast muscle, brain, and optic nerve 
(Ferrari et al., 1987; Rajavashisth et al., 1987; Byrnes et al., 
1987).  The level of these messages appeared to be develop- 
mentally regulated, particularly in liver, breast muscle, and 
intestine. 
In this report, we present evidence that the apo A-I gene 
is actively expressed in the avian peripheral nerve. Expres- 
sion of this gene is developmentally regulated, in parallel 
with the rapid phase of myelination. These findings support 
the hypothesis that apo A-I synthesized within the nerve par- 
ticipates in the local transport oflipids used in myelin biosyn- 
thesis. 
Materials and Methods 
Northern Blots 
Sciatic nerves, from embryos or chicks (of various developmental stages), 
were dissected as described previously (Hu and Mezei, 1971). This tissue 
was immediately frozen in liquid nitrogen, and poly (A)  + RNA was ex- 
tracted by a modification of the hot phenol (LeBlanc and Mezei, 1985) or 
the guanidine isothiocyanate/hot phenol method (Maniatis et al.,  1982) as 
described recently (LeBlanc et al., 1987).  Poly (A)  + RNA was purified by 
twa successive cycles of binding to oligo(dT)-cellulose (Maniatis et al., 
1982). 
Northern analysis of total RNA was carried out on formaldehyde gels as 
described by Maniatis et al. (1982) with the following modifications. RNA 
(29-40 p.g) was denatured at 650C  for 12 min in 50%  formamide, 2.2 M 
formaldehyde, and 0.5x running buffer (Ix running buffer is 20 mM 3-[N- 
morpholino]-pmpanesulfonic  acid, 5 mM sodium acetate,  1 mM Na2EDTA, 
pH 7) and quickly cooled on ice for 2 min. A 1.3% agarose gel containing 
2.2 M formaldehyde, lx  running buffer, and 0.5 ttg/ml ethidium bromide 
was prepared, and samples were electropboresed in lx  running buffer at 
40 V for 18 h. Transfer of  formaldehyde-denatured RNA onto nitrocellulose 
was carried out as described by Maniatis et al.,  1982.  The 500-bp eDNA 
(pCSN-2) insert from the eDNA clone encoding the partial sequence of the 
chick apo A-I gene (nucleotide residues 530-959 according to Rajavashisth 
et al.,  1987)  was separated from the plasmid by Eco RI digestion of the 
recombinant plasmid DNA according to Maniatis et al.  (1982),  and the 
purified restriction fragments were labeled by random priming (Feinberg 
and  Vogelstein,  1983)  to a  specific activity of 2.5-5  x  10  a cpm//~g  of 
DNA. 
Slot Blots 
2  /zg of poly(A)+RNA was  diluted by  1:2  serial  dilutions and  applied 
through a  nitrocellulose membrane fitted in a  slot-blot apparatus as de- 
scribed recently (LeBlanc et al.,  1987). 
Subcellular Fractionation 
Sciatic nerve tissue was dropped into liquid nitrogen upon dissection and 
ground with a mortar and pestle without allowing the tissue to thaw.  The 
po~er was then transferred into 12 vol of 0.85  M sucrose, 1 mM EDTA 
and homogenized for 2 min at 2,500 rpm in an all-glass tissue homogenizer 
(Kontes Glass Co., Vineland, NJ). The homogenate was subjected to discon- 
tinuous density gradient centrifugation to prepare crude myelin and related 
membranes according to a slightly modified procedure of Mezei and Ver- 
poorte (1981) (Fig.  1). Typically 2.4 ml of tissue homogenate in the above 
solution was layered onto 1 ml of 1.2 M  sucrose. Then 0.8 ml of 0.32  M 
sucrose was layered on top and the sample was subjected to centrifugation 
at  100,000 g  for 120 min at 4°C. Six fractions (not osmotically shocked) 
were recovered from this gradient: supernatant 1 in 0.32 M sucrose; crude 
myelin layer at the 0.32/0.85  M  sucrose interface; supernatant 2  (S-2) in 
0.85 M sucrose; a very thin "lower band" fraction at the 0.85/1.2 M sucrose 
interface (corresponding to a  similar band previously described for the 
chick sciatic nerve by Oulton and Mezei, 1976); supernatant 3 in 1.2 M su- 
crose; and a pellet. The crude myelin fraction was subjected to ~osmotic 
shock" treatment by diluting it with 10 vol of ice-cold distilled water, fol- 
lowed by  10 strokes of hand homogenization in a homogenizer (Dounce; 
Kontes Glass Co.). The suspension was allowed to stand on ice for 15 rain 
and centrifuged at 32,800 g for 30 min. The resulting supernatant solution 
(the SO fraction) was collected and further analyzed for the presence ofapo 
A-I-containing lipoprotein particles. The myelin pellet was washed once 
with 20 vol of ice-cold distilled water followed by centrifugation at 32,800 g 
for 30 min and subjected to a second cycle of  discontinuous sucrose gradient 
centrifugation as described above.  The  purified myelin fraction,  which 
again formed a sharp band at the interface between the 0.85 and 0.32 M su- 
crose layers,  was removed and washed five times with 20 vol of water as 
described above. 
SDS-PAGE and lmmunoblot Analysis 
Sciatic nerve homogenates and subcellular fractions were prepared for elec- 
trophoresis by  diluting  them  with  a  deoxycholate solufon  and  protein 
solubilizer (4% ~-mercaptoethanol, 0.25 M "Iris, pH 8.6, 192 mM glycine, 
and 1% SDS) to obtain a final solution containing 0.05%  deoxycholate and 
75%  protein solubilizer.  These were boiled for 2  min and then cooled. 
Dye/glycerol (1.25%  [wt/vol] bromophenol blue, 7.5%  [vol/vol]  glycerol) 
was added at 0.2 % (vol/vol) before applying the sample on the electrophore- 
sis gel. The electrophoresis, transfer of proteins to a nitrocellulose mem- 
brane, and immunoblotting were carried out as described by Nunn and 
Mezei (1984). The monospecific  anti-chick plasma apo A-I antiserum (Blue 
et al.,  1982)  was used at a  1:1,000 dilution and anti-chick PO antibody 
(anti-chick apo A-I free as demonstrated by enzyme linked immunoabsor- 
bant assay) at a  1:7,500 dilution. The second antibody was anti-rabbit IgG 
conjugated to alkaline phosphatase at  1:7,500 dilution. 
Isolation  of Lipoprotein  Fractions 
Subcellular fractions of chick sciatic nerve were separated into fractions 
corresponding to standard plasma lipoprotein fractions. The subcellular 
fractions were dialyzed overnight against a solution of 0.15 M NaCI, 0.001% 
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Figure 1. Scheme of subcellular fractionation used to prepare crude 
myelin and related membranes. 
sodium azide, pH 7.6, and adjusted to a density of 1.21 g/ml with potassium 
bromide followed by ultracentrifugation (40,000 rpm in a rotor [50:3; Beck- 
man Instruments, Inc., Fullerton, CA]) for 24 h. The supernatant and in- 
franatant fractions were recovered for analysis or for additional fraction- 
ation. In some instances the d <  1.21 g/ml was dialyzed against a solution 
of 0.15 M NaCI containing 0.001% sodium azide (pH 7.6) and subjected to 
sequential ultracentrifugal flotation of lipoprotein fractions in a rotor (50:3; 
Beckman Instruments, Inc.) at d  =  1.006 g/ml (18 h at 40,000 rpm), d  = 
1.063 g/ml (20 h at 40,000 rpm), and d  =  1.21 g/ml (24 h at 40,0(X) rpm). 
Analysis of  Lipoprotein 
Intact lipoproteins ofd <  1.21 g/ml from sciatic nerve subceilular fractions 
were separated  on  nondenaturing  4-30%  polyacrylamide gradient gels 
(Pharmacia Chem. Co., Montreal, Qu6bec, Canada) by slight modification 
of the procedure of Nichols et al. (1983).  The gels were preelectrophoresed 
for 20 rain at 125 V before sample application. The samples were applied 
and electrophoresed for 20 min at 70 V followed by electrophoresis at 20°C 
for 20 h at 125 V. Gels were either stained with Coomassie brilliant blue 
or transferred to nitrocellulose for immunoblotting. The transfer was per- 
formed as previously (Nunn and Mezei, 1984),  except that 0.02% SDS was 
added to the transfer buffer,  and transfer was carried out at 4°C for 24 h 
at 30 V. The lipids in the lipoprotein fractions were quantitated by gas-liquid 
chromatography of total lipid profiles as described by Tam and Breckenridge 
(1983). 
Negative Staining and Electron Microscopy 
Aliquots of S-2 and SO subcellular fractions were mounted on copper grids 
coated with formvar and carbon. After 5 rain, the excess liquid was removed 
and the sample was stained with 2% uranyl acetate for 20 s. The samples 
were viewed in an electron microscope (200;  Philips Electronic Instru- 
ments, Inc., Mahwah, NJ) and photographed. 
Detection of  apo A-I and PO Protein In Situ 
Sciatic nerves were removed from anesthetized l-d chicks or 22-d rats after 
several minutes of fixation in situ with 4% (wt/vol) paraformaldehyde PBS 
(7.53 mM disodium hydrogen phosphate, 2.5 mM monosodium dihydrogen 
phosphate, and 145 mM sodium chloride, pH 7.1). The nerves were trans- 
ferred to 4% formaldehyde in PBS and after an additional 4-h fixation they 
were embedded in paraffin by standard procedures. 4-6-#m-thick sections 
were immunostained according to the peroxidase-antiperoxidase method of 
Sternberger et al. (1970)  with slight modifications. All sections were ini- 
tially treated with 3 % hydrogen peroxide in methanol to block endogenous 
peroxidase and 10% normal swine serum to reduce nonspecific binding of 
antiserum. Selected sections were treated with primary antiserum, rabbit 
anti-chick apo A-I at 1:100 dilution, and rabbit anti-chick PO lgG at 1:!,000 
dilution. Control sections were treated with preimmune serum at 1:100 dilu- 
tion. The sections were then incubated with swine anti-rabbit serum (1:30 
dilution) and with rabbit peroxidase-antiperoxidase complex (Dimension 
Laboratories,  Mississauga, Ontario,  Canada).  Color reaction was devel- 
oped with 0.016 % diaminobenzidine tetrahydrochloride and 0.005 % hydro- 
gen peroxide. Sections were counterstained with Mayer's hematoxylin. 
Labeling of Sciatic Nerves in Organ Culture 
Sciatic nerves from l-d chicks were dissected free of connective and other 
adherent tissue and placed immediately into sterile Krebs-Ringer solution 
containing 2  mg glucose/ml and previously saturated  with 95%  02/5% 
CO2  at 2°C as described previously (Hu and Mezei,  1971). Aliquots of 
0.25 g nerve tissue were incubated for 4 h at 37°C under an atmosphere of 
95%  02/5%  C02  in 0.4  ml  of the above medium containing 500  #Ci 
[35S]methionine  (800 Ci/mmol L-[35S]methionine,  translation grade) and 
25  ttCi  [14Clamino  acid mixture ([14C]U-L-amino  acid protein labeling 
mixture; DuPont of Canada Ltd., Montr6al, Qu6bec, Canada). After incu- 
bation, the medium was carefully removed by centrifugation and dialyzed 
against 2 liters of  0.02 M sodium phosphate, pH 7.4, 0.15 M sodium chloride 
containing 100 mg PMSE 0.05  mg/ml NAN3, and  1%  (vol/vol) mercap- 
toethanol. The remaining nerve tissue was washed three times with ice-cold 
Krebs-Ringer solution followed by centrifugation at 600 g for 5 min. The 
tissue was then homogenized and centrifuged to prepare a high-speed super- 
natant according to Capony and Williams (1980).  Another aliquot of sciatic 
nerve tissue, incubated and labeled as described above, was subjected to 
subcellular fractionation as described in a previous section to obtain purified 
myelin and related subcellular fractions. 
lmmunoprecipitation 
Labeled tissue extracts, subcellular fractions, and  medium were reacted 
with excess anti-chick apo A-I or anti-chick PO (anti-apo A-I-free) anti- 
bodies or preimmune serum in a double antibody procedure according to 
Blue et al. (1980) and LeBlanc et al. (1987).  Protein A-Sepharosc (Pharma- 
cia Chem. Co.) was used as second antibody. Washed immunoprecipitates 
and original tissue extracts were fractionated by SDS-10% polyacrylamide 
slab gels as described previously (Nunn and Mezei, 1984). Radioactive pro- 
teins were visualized by fluorography (Bonner and Laskey, 1974). Low mo- 
lecular weight protein standards (Pharmacia Chem. Co.) were routinely run 
on the gels for molecular weight calibration. 
Results 
Isolation and Sequence of  a Chick apo A-I 
cDNA Clone 
We prepared eDNA banks with mRNA isolated from sciatic 
nerves of 19-d chick embryos or l-d posthatch chicks to ob- 
tain eDNA libraries containing maximum amounts of my- 
elination-specific gene products. Immunoscreening of a Xgt 
11 expression eDNA library with polyclonal anti-chick PO 
antibody yielded a 200-bp recombinant eDNA. The sequence 
of the first isolates was homologous to the 3' regions of chick 
apo A-I mRNA. This unexpected result was subsequently ex- 
plained by demonstrating that the anti-chick PO IgG fraction 
contained a relatively high titer of anti-apo A-I antibodies. 
The apo A-I antibodies possibly arose from small amounts 
of apo A-I contaminating the purified PO antigen used to 
raise the polyclonal antibodies. Both PO protein and apo A-I 
have molecular masses of 28-30 kD.  Screening of a pUC8 
cDNA library from 1-d chick sciatic nerve with the 200-bp 
initial  isolate yielded a  500-bp apo A-I eDNA  clone that 
showed 100%  identity to 291  nucleotides of the coding re- 
gion corresponding to the carboxy terminus of the chick apo 
A-I protein and 186 bp of the 3' noncoding region of the re- 
cently published chick apo A-I sequence from a chicken liver 
cDNA library (Rajavashisth et al.,  1987). 
LeBlanc et al. Apo A-I and Myelination  in Avian  Peripheral  Nerve  1247 Figure 2. Northern and slot-blot analysis of mRNA from sciatic nerve, brain, and liver. (,4) Northern blot analysis of total RNA prepara- 
tions. The cDNA probe isolated from our l-d-old chick sciatic nerve library and encoding nucleotide residues 530-959 of the eDNA clone 
reported by Rajavashisth et al. (1987) was hybridized to 29 (lanes 1 and 3-9) and 40/~g (lane 2) of total RNA.  (Lanes 1-6) Total RNA 
from sciatic nerves of 15-, 17-, and 19-d embryonic and 1-, 3-, and 7-d posthatch chicks, respectively;  (lane 7) wheat germ rRNA; (lane 
8)  19-d embryonic chick brain; (lane 9)  19-d embryonic chick liver. The arrows indicate the position of 28 and  18 S rRNA markers on 
the gel. (B) Slot-blot analysis of poly(A) + RNA preparations.  One in two serial dilutions of 2 #g poly(A) + RNA were applied on nitrocel- 
lulose filters and hybridized with the 32p-labeled ape A-I cDNA probe as in A. (Lanes 1-6) Poly (A)  ÷ RNA, respectively, from 15-, 17-, 
and  19-d embryonic and  1-, 3-, and 7-d posthatch sciatic nerve;  (lane  7) wheat germ rRNA;  (lane 8)  19-d embryonic liver RNA.  (C) 
Slot-blot analysis of poly(A) ÷ RNA preparations  shown in B, stripped and rehybridized with 32p-labeled histone variant H3.3 eDNA (En- 
gel et al.,  1982) as a control probe. 
Developmental Expression of  apo A-I mRNA 
in the Sciatic Nerve 
To assess the size and abundance of apo A-I mRNA in the 
chick  sciatic  nerve,  we  used  the  500-bp  eDNA  probe in 
Northern and slot-blot analysis of mRNA preparations (Fig. 
2,  A  and  B).  Substantial  amounts  of apo A-I mRNA are 
found in the rapidly myelinating chick sciatic nerve (Fig. 2 
A, lanes 2-6). The message is barely detectable in 15-d em- 
bryonic nerve (Fig. 2 A, lane/) whereas no signal could be 
detected in nonmyelinated 12-d embryonic nerves (result not 
shown). The size of the transcripts (~1 kb), estimated from 
their migration relative to rRNA on the gels, is the same as 
that obtained from chick liver (lane 9) or chick brain (lane 
8).  As expected wheat germ rRNA does not show any hy- 
bridization with the cDNA probe (lane 7). To obtain a better 
quantitation of the relative levels of apo A-I message from 
sciatic nerves of different developmental stages, we carried 
out slot-blot analysis of poly(A)+RNA preparations. Fig. 2 
B  shows about an eightfold increase in the level of apo A-I 
mRNA in the sciatic nerve from the  15-d embryonic devel- 
opment to the 3-d posthatch stage (cf. lanes I and 5). Myelin- 
specifc genes and genes associated with the process of my- 
elination are expected to increase during the phase of rapid 
myelination.  Gene products not directly involved with my- 
elination may show a different pattern. To demonstrate that 
the pattern of apo A-I gene expression does not merely reflect 
a general increase in transcriptional activity of the develop- 
ing sciatic nerve we used the replication-independent histone 
variant H3.3 cDNA as a control probe (Engel et al.,  1982). 
This gene has been used as control in other investigations of 
neural development (Vardimon et al.,  1986).  Fig. 2 C shows 
that levels of H3.3 coding transcripts are higher in the early 
stages of embryonic development than those of the posthatch 
animals.  This is in contrast to the pattern observed for the 
apo A-I message. We may then conclude that the level of apo 
A-I transcripts increases during the active phase of myelina- 
tion in the chick sciatic nerve (Uyemura et al.,  1979;  Nunn 
et al.,  1987). 
Immunochemical Detection and SubceUular 
Localization of  apo A-I Protein in the Sciatic Nerve 
To investigate whether the chick sciatic nerve contains sub- 
stantial amounts of apo A-I protein, we fractionated sciatic 
nerve total  protein  extracts  on  SDS-polyacrylamide gels. 
Western blot analysis of these gels with monospecific anti- 
chick apo A-I antiserum (Blue et al., 1982) demonstrates im- 
munostaining of a protein band in the sciatic nerve homog- 
enates  (Fig.  3,  lanes  2-7)  and  subcellular  fractions  (lanes 
8-13) that  has  the  same mobility as  purified chick serum 
HDL proteins (lane/).  The high molecular weight protein 
bands in some of the preparations may represent aggregated 
forms of the apo A-I protein (Scanu et al.,  1982).  Densito- 
metric comparison of the immunostained protein bands indi- 
cated maximum immunostaining per unit of total protein in 
nerve homogenates of 1-d-old chicks.  The quantity  of apo 
A-I-like immunoreactive material is '~3.5 times as great at 
1-d posthatch as at the 15- or 17-d embryonic stage (lanes 2, 
3, and 5). The increase in the level of the translation products 
during nerve development is comparable, although not iden- 
tical, with the developmental pattern of apo A-I transcripts 
shown by Northern analysis (Fig.  2 A). 
Ifapo A-I has a role in the myelination process of the PNS, 
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enates and subcellular fractions. Proteins were fractionated on 10% 
SDS-polyacrylamide  gels and electroblotted.  The nitrocellulose 
sheets  were  immunostained  with  anti-chick apo A-I antiserum 
(1:1,000 dilution). Approximately 5/zg of total protein was applied 
in each lane, except in lane 1 which contained ,x,0.2 ~g protein. 
(Lane  1)  Delipidated  chick serum  HDL proteins;  (lanes  2-4) 
sciatic nerve homogenates from 15-, 17-, and 19-d embryos; (lanes 
5-7) sciatic  nerve  homogenates  from  1-,  3-,  and  7-d posthatch 
chicks; (lane 8) purified myelin; (lane 9) SO fraction; (lane 10) su- 
pernatant 3; (lane//) supernatant 1; (lane 12) lower band; (lane 13) 
S-2. The arrow and number on the side indicate the mobility and 
molecular weight of the 30K protein marker. 
we would expect the protein to be present in cellular or sub- 
cellular fractions related to the myelin membrane. To explore 
the subcellular localization of apo A-I in the tissue, we sub- 
jected sciatic nerve homogenates to a  subcellular fraction- 
ation procedure that yields various soluble, particulate, my- 
elin-related,  and  highly purified myelin fractions (Oulton 
and Mezei, 1976; Lewis et al., 1984). apo A-I-like immuno- 
reactivity was detected not only in the previously well-char- 
acterized and highly purified myelin fraction (Fig. 3, lane 8), 
but also in other subcellular fractions obtained during the 
purification procedure (lanes 9-13; for details of subcellular 
fractionation see Fig. 1). Two subcellular fractions, SO (Fig. 
3, lane 9) and S-2 (lane 13), were enriched about twofold in 
apo  A-l-like  immunoreactivity  when  compared  with  the 
original homogenate (lane 5). The SO fraction (lane 9) rep- 
resents the supernatant fraction of crude myelin membranes 
subjected to osmotic shock treatment with cold distilled wa- 
ter; it therefore represents a myelin-derived fraction. Waeh- 
neldt  (1978)  suggested  that  osmotic  shock  treatment with 
cold water removes the hypoosmotically labile portions of 
the  myelin superstructure,  yielding a  fraction enriched in 
tongue and loop regions and some shavings of lamellae ini- 
tially involved in the compaction process of myelin forma- 
tion. We speculate this fraction may also contain transitional 
forms of the Schwann cell membrane involved in myelin as- 
sembly. The S-2 fraction (lane 13) was obtained at 0.85  M 
sucrose,  between the crude myelin layer and  a  thin  band 
above the 1.2 M sucrose cushion after the first discontinuous 
sucrose gradient cycle. This fraction probably corresponds 
to the soluble, cytoplasmic compartment of the sciatic nerve, 
but it also contains some membrane fragments derived from 
the myelin sheath (Lewis et al.,  1984). 
The resolution of the subcellular fractionation was tested 
by immunostaining the proteins of the subcellular fractions 
with anti-chick PO antibody.  As  expected and previously 
demonstrated (Nunn et al.,  1987),  PO protein, the major 
glycoprotein marker of the PNS myelin, was enriched in the 
highly purified myelin fraction (results not shown). A large 
proportion ofapo A-I can be released from myelin by the os- 
motic  shock  treatment.  However,  a  small  but  significant 
amount of apo A-I protein copurifies with highly purified 
myelin preparations. We confirmed the latter result by puri- 
fying myelin from 15- and 19-d embryonic and 7-d posthatch 
chicks and demonstrating the presence of significant amounts 
of apo A-I-like immunoreactivity in the preparations (result 
not shown). Our subcellular fractionation experiments thus 
indicate that apo A-I is present in the soluble portion of the 
sciatic nerve homogenates. Some of the polypeptide is also 
physically associated or entrapped within the myelin mem- 
branes. 
lmmunohistocheraical Demonstration of  apo A-I 
in the Chick Sciatic Nerve 
We confirmed the presence of apo A-I protein within the 
sciatic nerve by immunohistochemical light microscopy of 
4-6-#m sections of sciatic nerve preparations. Fig. 4, A and 
B, shows immunostaining of  the endoneurial compartment of 
sciatic nerve with anti-apo A-I antibody. Higher magnifica- 
tion views (Fig. 4, A' and B') indicate that some subcompo- 
nents of endoneurial cells and the extracellular matrix are 
also  immunostained.  As  expected, myelin of chick sciatic 
nerve is heavily stained with the myelin-specific anti-chick 
PO antibody (C and D).  Control experiments with preim- 
mune serum (E and F)  showed no reaction. Furthermore, 
specificity of antisera was demonstrated by carrying out the 
same type of experiments with rapidly myelinating, 21-23-d- 
old rat sciatic nerves. The results (not shown) demonstrated 
that  anti-chick  PO  antibodies  immunostained  the  myelin 
sheath, whereas anti-chick apo A-I showed no specific im- 
munostaining in rat sciatic nerve sections. Therefore, it ap- 
pears that apo A-I-like immunoreactivity is localized spe- 
cifically in  Schwann  cells and  extracellular matrix of the 
chick sciatic nerve. 
Biosynthesis and Secretion of  apo A-I Protein in 
Chick Sciatic Nerve 
The series of experiments described above were designed to 
show  the  presence of apo  A-I  transcripts  and  translation 
products in the sciatic nerve. To demonstrate de novo syn- 
thesis of apo A-I and apo A-I-containing lipoprotein parti- 
cles, sciatic nerves from  1-d chicks were incubated with a 
[35S]methionine-[~4C]amino  acid mixture for 4  h  in organ 
culture. SDS-PAGE of the protein extracts followed by auto- 
radiography revealed the presence of many radioactive pro- 
teins  in  the  nerve  (Fig.  5,  lane  /)  and  in  the  incubation 
medium (lane 7). Newly synthesized apo A-I (lane 2) and PO 
proteins (lane 3) could be detected in the nerve by immuno- 
precipitation of these proteins from the nerve homogenate 
(lane/) with anti-chick apo A-I and anti-chick PO antibod- 
ies, respectively. The purified myelin fraction also contained 
LeBlanc et al. Apo A-I and Myelination  in Avian Peripheral Nerve  1249 Figure 4. Immunocytochemical  demonstration  of apo A-I protein in chick sciatic nerve. Brown peroxidase reaction product marks the loca- 
tion of apo A-I protein or PO protein.  (A and B) 4-6-/~m sections of paraffin-embedded  1-d chick sciatic nerve incubated in anti-chick 
apo A-I antiserum (1:100 dilution); (C and D) consecutive sections of the same nerve, but incubated in anti-chick PO 3,-globulin solution 
(1:1,000 dilution); (E and F) consecutive sections of the same nerve, but incubated in preimmune serum (1:100 dilution). Bars: (A, C, and 
E) 20 ~m; (B, D, and F) 50 tzm; (A'-D')  12.5 #m. 
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sciatic nerve.  Sciatic nerves were incubated with a  [35S]methio- 
nine-[z4C]amino acid mixture in short-term organ culture. Tissue 
protein extracts and incubation medium were fraetionated by SDS- 
PAGE, and newly synthesized proteins were detected by autora- 
diography. (Lanes I and 7) Total proteins from the 226,000-g super- 
natant of homogenized nerves  (3.1  x  105 cpm)  and  incubation 
medium (2.7 x  I(P cpm), respectively; (lanes 2 and 4) total pro- 
teins immunoprecipitated with anti-chick apo A-I antisera from the 
226,000-g supernatant of nerve homogenates (1.7 x  106 cpm) and 
incubation medium (2.9  x  l0  s cpm), respectively; (lanes 3 and 5) 
total proteins immunoprecipitated with anti-chick  PO ),-globulins 
from the 226,000-g supernatant of nerve homogenates (1.7 x  106 
cpm) and incubation medium (2.9  x  1@ cpm), respectively; (lane 
6) total proteins immunoprecipitated with preimmune serum from 
the incubation medium (2.9  x  105 cpm);  (lane 8) total proteins 
from the purified myelin fraction. The arrows and numbers on the 
side indicate the mobility and molecular weights of low molecular 
weight protein markers  (Pharmacia Chem.  Co.).  The gels were 
processed for fluorography (Bonner and Laskey, 1974), and lanes 
2-6 were exposed on XOMAT-AR x-ray film (Eastman Kodak Co., 
Rochester, NY) for 25 h. Lanes 1, 7, and 8 were exposed for shorter 
or longer times to facilitate visualization of the individual radioac- 
tive protein bands. 
newly synthesized myelin proteins,  including the  ,,o30-kD 
PO glycoprotein and the smaller basic proteins (lane 8). Im- 
munoprecipitation of radioactive apo A-I protein from the in- 
cubation medium (lane 4) demonstrated the secretion of this 
apolipoprotein by the chick sciatic nerve. Although almost 
six times as much radioactive total protein was used for the 
immunoprecipitation of apo A-I and PO proteins from the 
high-speed supernatant of nerve homogenates as from the in- 
cubation medium,  the intensity of the immunoprecipitated 
apo A-I band was twice as high in the incubation medium (cf. 
lanes 2 and 4). This indicates that a large proportion of the 
newly synthesized apo A-I translation product was released 
from the nerves. As expected, the integral membrane glyco- 
protein  PO  was  not  secreted by the  tissue  (lane 5).  This 
demonstrated the specificity of the secretion process. The 
specificity of the immunoprecipitation is shown by the ab- 
sence of radioactive protein bands when immunoprecipita- 
tion was carried out with preimmune serum (lane 6). Fur- 
thermore,  the  presence  of  a  large  excess  of  unlabeled 
antigens (HDL proteins and PO protein) eliminated the im- 
munoprecipitation of newly synthesized radioactive antigens 
(results  not  shown;  see  Blue  et  al.,  1982;  LeBlanc  and 
Mezei,  1985). 
Detection of  Lipoprotein-like Particles in Subceilular 
Fractions of  Sciatic Nerve 
Apolipoproteins normally occur in vivo in association with 
lipid to form lipoprotein particles. We deemed it important 
to determine whether apo A-I was associated with lipid in the 
sciatic nerve. Therefore, we subjected the subcellular frac- 
tions enriched in apo A-I to ultracentrifugation in KBr solu- 
tion adjusted to a density of 1.21 g/ml.  Ultracentrifugation 
yielded two major fractions: a fraction which floated on top 
of the 1.21 g/ml solution (d <  1.21 g/ml) and another with 
d >  1.21 g/ml. We analyzed these fractions by SDS-gel elec- 
trophoresis followed by immunoblotting and estimated that 
>60% of the total apo A-I and >80% of the total PO protein 
of the SO and S-2 fractions could be recovered in the "float- 
ing fraction" with d <  1.21 g/ml. These results indicated that 
a high proportion of the apo A-I protein (and, as expected, 
the PO protein) is associated with lipid within the sciatic 
nerve. We therefore further analyzed this floating fraction for 
the presence of lipoproteins and for lipid composition. Non- 
denaturing gradient gel electrophoresis that separates lipo- 
protein particles according to size (Nichols et al., 1983) was 
used. Coomassie blue staining of this gel detected two major 
protein bands in the S-2 and SO subfractions (Fig. 6 A, lanes 
3  and 4,  respectively) that have mobilities similar but not 
identical to chick serum HDL particles (Fig. 6, lane 2). The 
chick serum very low density lipoprotein (VLDL)-Iow den- 
sity lipoprotein (LDL) fraction showed the presence of large 
particles barely entering the gel (Fig. 6 A, lane/). Control 
experiments with delipidated S-2 fraction (Fig. 6 A, lane 6) 
showed a shift in mobility of the delipidated protein bands 
in a fashion similar to those of the delipidated chick serum 
HDL proteins (Fig. 6 A, lane 5). Immunostaining of a blot 
of a duplicate gel with anti-chick apo A-I antibodies con- 
firmed the presence of apo A-l-containing lipoprotein parti- 
cles in the S-2 and SO subfractions (Fig. 6 B, lanes 3 and 
4, respectively) that have mobilities similar but not identical 
to chick serum HDL particles (Fig. 6 B, lane/). The speci- 
ficity of immunostaining is further demonstrated by the ab- 
sence of immunoreactivity in the chick serum VLDL-LDL 
fraction (Fig. 6 B, lane 2). However, these apo A-I-contain- 
ing lipoproteins in S-2 and SO subcellular fractions were not 
immunoreactive with anti-PO or anti-apolipoprotein B (apo 
B)  antisera  when  subjected  to  nondenaturing  PAGE  and 
Western  blotting  (results  not  shown).  These  experiments 
demonstrated that PO protein and apo B are not components 
of  the HDL-like lipoprotein particles. The autoradiograms of 
immunoblots of S-2, SO, and incubation medium of sciatic 
nerves labeled with a  [35S]methionine  and [14C]amino acid 
mixture in organ culture also indicate that this tissue can syn- 
thesize (Fig. 6 B, lanes 7 and 8) and secrete HDL-like lipo- 
protein particles into the extracellular space (Fig. 6 B, lane 6). 
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gel electrophoresis and immunoblotting of subcel- 
lular fractions of chick sciatic nerve.  The S-2 and 
SO subcellular fractions, serum HDL, and VLDL- 
LDL fractions  isolated  after potassium bromide 
ultracentrifugation  and the incubation medium and 
S-2 and SO subcellular  fractions of l-d chick sci- 
atic nerves  labeled  with a [35S]methionine-['4C] - 
amino acid mixture in organ culture were analyzed 
on  4-30%  nondenaturing  polyacrylamide  gels. 
The proteins  on the gels were stained  with  Coo- 
massie brilliant  blue (A) or transferred  to nitrocel- 
lulose for immunoblotting (B). The blots were im- 
munostained  with  anti-chick apo A-I antiserum 
(1:1,000 dilution) and the stained blots subjected to 
autoradiography  to detect  newly synthesized  en- 
dogenous  and  secreted  apo  A-I proteins.  In A: 
(lane 1 ) 1-d chick serum VLDL-LDL; (lane 2) l-d 
chick serum HDL; (lane 3) S-2 fraction;  (lane 4) 
SO fraction; (lane 5) delipidated  l-d chick serum 
HDL proteins; (lane  6) delipidated  S-2 fraction; 
(lane  7) high molecular weight protein standards 
(Pharmacia Chem. Co.). The arrows and numbers on the side indicate  the mobility and molecular weights of the protein  markers.  In B: 
(lane 1 ) chick serum HDL, (lane 2) chick serum VLDL-LDL fraction; (lane 3) S-2 fraction; (lane 4) SO fraction; (lane 5) delipidated 
chick serum HDL proteins; (lanes 6--8) autoradiograms of immunoblots of the incubation medium and S-2 and SO subcellular  fractions 
of 1-d chick sciatic nerves labeled with [35S]methionine-[~4C]amino acid mixture for 4 h in organ culture.  X-ray films of immunoblot lanes 
6-8 were exposed for various time periods to facilitate  visualization  of the individual  radioactive  protein bands. 
To investigate further the chemical nature of the lipids as- 
sociated with the lipoprotein particles in the sciatic nerve, we 
analyzed the lipids in the S-2 and SO floating fractions (d < 
1.21 g/ml). Table I shows that both of these subcellular frac- 
tions contained cholesteryl esters and triacylglycerols, sug- 
gesting the  presence  of neutral  core lipoprotein-like  parti- 
cles. The supernatant fractions (d =  1.21 g/ml) from S-2 and 
SO were further resolved into subfractions corresponding to 
serum  VLDL  (d  <  1.006  g/ml),  LDL  (d  =  1.006-1.063 
g/ml), and HDL (d =  1.063-1.21 g/ml) as shown in Table I. 
Very small amounts of lipid were present in the VLDL frac- 
tion, clearly indicating that the majority of cholesteryl ester 
and triacylglycerol was not associated with nondefined float- 
ing fat.  There were substantial  amounts of all lipid classes 
in the LDL- and HDL-like fractions.  Although most of the 
lipid  in  S-2  was  present  in  the  HDL-like  fraction,  in  the 
SO fraction the lipid in the LDL-like fraction was the most 
abundant. 
All  subfractions  of  S-2  had  substantial  amounts  of 
cholesteryl ester and triacylglycerol which is characteristic 
of neutral core lipoproteins  for these density classes.  How- 
ever,  in SO the majority of the lipid mass in the LDL- and 
HDL-like  fractions  was cholesterol  and phospholipid.  All 
fractions  contained  higher  proportions  of cholesterol  than 
serum lipoproteins. In view of the substantial amounts of PO 
protein it is probable that there are some myelin membrane 
fragments in these lipoprotein-like fractions.  However, dis- 
coidal HDL particles  (Pitas  et al.,  1987),  as well as HDL 
Table L Composition of  Subfractions  of  S-2 and SO Corresponding  to Standard Lipoprotein  Fractions 
Subfraction of peripheral nerve* 
S-2  SO  Plasma~ 
d  <  1.006  d  =  1.006-  d  =  1.063-  d  <  1.006  d  =  1.006-  d  =  1.063-  VLDL 
Total  g/ml  1.063 g/ml  1.21  g/ml  Total  g/ml  1.063 g/ml  1.21  g/ml  +  LDL  HDL 
Lipid mass 
distribution 
(% of total) 
100  3.3  18.4  78.3  100  6.0  63.2  30.8 
Composition 
(wt%)§ 
C  21.9  +  2.2  10.4  20.7  19.9  22.4  +  7.1  4.9  17.8  32.8  12.3  6.3 
CE  23.3  +__ 5.7  43.5  29.4  19.9  14.3 ±  7.9  25.1  5.8  3.4  47.8  39.2 
PL  44.2  +  7.4  21.9  34.2  50.9  47.8  ±  8.8  26.8  57.5  52.8  34.5  51.3 
TG  10.6 ±  2.9  24.2  15.7  5.2  15.9 ±  2.5  43.2  18.9  11.1  5.4  3.2 
* Preparations of S-2 and SO were adjusted to d  =  1.21  g/ml and centrifuged for 24 h  in a  rotor (50.3;  Beckman Instruments, Inc.) at 40,000 rpm to yield a 
supernatant containing the total membrane plus lipoprotein fraction which contained 98 % of the lipid. The supernatant fraction was dialyzed against NaCI solution 
(d  =  1.006 g/ml).  Standard lipoprotein fractions were isolated as described in the text. 
~t Serum lipoproteins were isolated from  l-d chicks as described in text. 
§ C, Cholesterol; CE, cholesteryl ester; PL, phospholipid; and  TG,  triacylglycerol. 
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ticles that are also assembled into stacks (B), similar to the 
HDL particles from chick serum (F). The mean diameters 
of spherical particles from the HDL-like fractions of the S-2 
and SO subcellular fractions were "~10 nm. This result is 
comparable with that reported for the spherical lipoprotein 
particles of human or canine cerebrospinal fluid and chick 
HDL fractions (Pitas et al.,  1987; Banerjee and Redman, 
1983).  These data are thus consistent with the presence of 
apo A-I-like immunoreactivity in the chick subcellular frac- 
tions that are associated with lipids. Some of the physico- 
chemical properties of  these lipoprotein-like particles resem- 
ble  those  of  lipoproteins  in  the  cerebrospinal  fluid  and 
peripheral lymph observed previously by other investigators 
(Pitas et al.,  1987; Sloop et al.,  1987). 
Figure 7. Electronmicrographs  of negatively  stained preparations of 
sciatic nerve S-2 and SO subcellular fractions and chick serum lipo- 
proteins. Negatively stained particles from lipoprotein fractions of 
1-d-old chick sciatic nerve S-2 (A and B); SO subcellular fractions 
(Cand D); and l-d chick serum (Eand F). (A and C) The particles 
had d  =  1.006-1.063 g/ml (LDL-like); (B and D) d  =  1.063-1.21 
g/ml (HDL-like); (E) d <  1.063 g/mi (serum VLDL-LDL frac- 
tion); and (F) d  =  1.063-1.21 g/ml (serum HDL). 
from cerebrospinal fluid, contain higher proportions of cho- 
lesterol than normal plasma HDL.  Furthermore, the high 
amount of lipid in the LDL-like fraction may be due to large 
apo A-I-containing lipoproteins similar to those described 
for peripheral lymph (Sloop et al.,  1987). 
Electronmicroscopic analysis further supported the results 
shown in  Table  I.  Electronmicrographs of the  negatively 
stained LDL-like fractions (d =  1.006-1.063 g/ml) from the 
S-2 and SO subcellular fractions show the presence of vesic- 
ular structures and spherical particles (Fig. 7, A and C) that 
probably  represent  myelin  fragments  and  resemble  the 
VLDL-LDL fraction of 1-d-old chick serum (E). The HDL- 
like fractions (d =  1.063-1.21) from the S-2 and SO subcellu- 
Discussion 
Our  investigations indicate that transcripts and translation 
products of the apo A-I gene are present in the avian periph- 
eral nerve. Moreover, the expression of this gene appears to 
be developmentally regulated during a period of nerve devel- 
opment that coincides with the phase of most rapid myelina- 
tion of peripheral axons (Uyemura et al., 1979; Nunn et al., 
1987).  These experiments disclose a new and hitherto un- 
suspected role for apo A-I in the myelination process of the 
avian PNS. Several lines of evidence support this role. 
We isolated a cDNA encoding the partial sequence of apo 
A-I from cDNA libraries of rapidly myelinating chick sciatic 
nerve. Positive clones in these libraries arose at a frequency 
of  0.3 %, indicating that apo A-I coding transcripts were rela- 
tively abundant in the tissue. A  relatively high abundance 
of the apo A-I transcripts in the sciatic nerve was also con- 
firmed by Northern analysis of the mRNA populations (Fig. 
2 A), providing evidence for the developmental regulation of 
the expression of the apo A-I gene. The level of mRNA is 
very low in the 15-d embryonic nerve, where the number of 
myelin lamellae around the growing axons is very small. 
Thereafter, the amount of apo A-I message increases rapidly 
up to 3-d posthatch, in parallel with the rapid deposition of 
myelin in the sciatic nerve. Recently, a similar developmental 
study ofapo A-I mRNA levels in various tissues was described 
in skeletal muscle, where this mRNA species is present at 
a high level only immediately after hatching (Rajavashisth et 
al.,  1987; Ferrari et al.,  1987).  In contrast, the low level of 
chick brain apo A-I mRNA does not appear to vary with age 
(Ferrari et al.,  1987).  It has been suggested that activation 
of apo A-I synthesis in muscle might be caused by the inner- 
vating motor neurons or by metabolic stimuli such as changes 
in lipid composition and concentration which occur at the 
time of hatching (Schackelford and Lebherz, 1983).  Similar 
types of mechanisms might be operating in the sciatic nerve. 
The developmental regulation of expression of the apo A-I 
gene is also demonstrated by our immunoblotting experi- 
ments  (Fig.  3).  apo  A-I  protein  is  detectable  in  nerve 
homogenates of 15-d embryos, and the level increases up to 
1-d posthatch. The accumulation of apo A-I protein appears 
to precede that of its transcripts. Although the apolipoprotein 
does not appear to be enriched in myelin, a portion remains 
tightly associated with myelin even after extensive purifica- 
tion (Fig. 3). Our immunohistochemical analysis confirmed 
the presence of apo A-I-like immunoreactivity in endoneu- 
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endoneurial cells. 
Our studies with organ cultures of sciatic nerves from 1-d 
chicks strengthen the evidence for local synthesis and secre- 
tion ofapo A-I by this tissue. Newly synthesized apo A-I was 
identified by immunoprecipitation with antibody specific to 
apo A-I of chick serum (Fig.  5).  The immunoprecipitated 
apo A-I synthesized by the sciatic nerve had the same relative 
mobility as apo A-I from chick serum. The newly synthe- 
sized apo A-I was secreted by the sciatic nerve in a form as- 
sociated with lipid (Fig. 6). Similar results were reported for 
chick muscle cells by Blue et al.  (1982).  As expected, the 
synthesis, but not the secretion, of the major peripheral my- 
elin protein, PO, also occurred under these conditions. 
Our working hypothesis that the nonneuronal cells of the 
avian sciatic nerve synthesize and secrete apo A-I associated 
with specific lipids was confirmed by showing the presence 
of HDL-iike particles in two subcellular fractions that proba- 
bly represent the cytoplasmic compartment actively involved 
in  the  synthesis  and  assembly  of myelin precursors.  The 
flotation properties (d <  1.21 g/ml) and the electromicro- 
scopic appearance of the negatively stained particles resem- 
bled those of HDL particles from chick serum (Fig. 7). The 
presence of cholesterol esters and  triacylglycerols in  this 
fraction (Table I) and the absence of these components in 
highly purified myelin (results not shown) further confirmed 
the association of apo A-I with classes of lipids normally 
found in lipoprotein particles.  One important difference is 
the high proportion of free cholesterol in the lipid extracts 
of chick sciatic nerve cytoplasmic fractions when compared 
with plasma HDL cholesterol (Scanu et al.,  1982). Interest- 
ingly, the lipid composition of the sciatic nerve lipoprotein 
fraction is similar to the free cholesterol enriched particles 
found in mammalian cerebrospinal fluid that are believed to 
be assembled locally (Pitas et al.,  1987). Our data are con- 
sistent with the notion that the sciatic nerve lipoprotein parti- 
cles are assembled locally in the nerve and are not derived 
from plasma. The possibility remains, however, that the high 
free cholesterol content of these subcellular fractions was 
partially due to contamination with myelin fragments result- 
ing from the freezing-thawing and homogenization proce- 
dures used to prepare the subcellular fractions. Experiments 
are in progress to further purify and characterize the lipopro- 
tein particles of the chick sciatic nerve. 
Our results, indicating that the apo A-I gene is actively ex- 
pressed  in  the  peripheral  nerve during  the time of rapid 
myelination, raise questions as to the role of apo A-I in my- 
elination.  A  number of laboratories reported recently that 
apolipoprotein E  (apo E) plays an  important role in lipid 
homeostasis, development, demyelination, and nerve repair 
in  the mammalian  nervous system (Dawson  et al.,  1986; 
Basheeruddin et al.,  1987;  Snipes et al.,  1987;  Ignatius et 
al., 1987). apo E has not been detected in avian lipoproteins, 
but apo A-I is  synthesized in a  variety of chicken tissues 
(Blue et al.,  1982), including the optic nerve in which apo 
A-I synthesis is increased fivefold during Wallerian degener- 
ation (Dawson et al., 1986). These results led to the proposal 
that apo A-I is the avian counterpart to mammalian apo E and 
the two proteins may perform functions common to both 
classes of animals in a variety of peripheral tissues (Dawson 
et al.,  1986). Two major functions have been proposed for 
these lipoproteins: the redistribution of lipids among cells of 
different organs and the redistribution of lipids among cells 
within an organ or tissue (Blue et al.,  1982,  1983; Dawson 
et al., 1986; Mahley, 1988). Recently Mahley (1988) empha- 
sized that other functions of apo E, unrelated to lipid trans- 
port,  are  becoming  known,  particularly  those  involving 
modulation of cell growth and differentiation. 
One of the most striking examples of cell-cell interactions 
and differentiation of a cell type is the myelination of central 
and peripheral axons. The formation of myelin imposes an 
enormous  burden  on  the  metabolism  of the  myelinating 
Schwann cell. It has been estimated that on the average, each 
cell makes an amount of myelin per day that is more than 
three times its own weight (Norton and Cammer, 1984). The 
avian myelin sheath is made up of 70%  lipid (Oulton and 
Mezei, 1976). Therefore, a burst of  phospholipid and choles- 
terol synthesis is required for proper biogenesis and assem- 
bly of this elaborate membrane.  We propose that apo A-I 
might be delivering lipid to the site of myelin formation. Our 
subcellular  fractionation  results  support  this  hypothesis 
since one of the fractions, SO, which may represent transi- 
tional forms of the Schwann cell membrane involved in my- 
elin assembly, was enriched in apo A-I associated with lipid. 
It is possible, however, that apo A-I association with this sub- 
cellular fraction arose during the fractionation of the tissue. 
The rapid rate of incorporation of cholesterol  into myelin re- 
quires active transport and this role could also be assumed 
by apo A-I. The plasma HDL particles with which apo A-I 
normally associates contain an abundant amount of choles- 
terol esters. It has also been shown that cholesterol esters are 
very high in the avian sciatic nerve at the onset of myelination 
(Mezei et al., 1971) as well as during Wallerian degeneration 
(Mezei, 1970). The increase of cholesterol esterase parallels 
this process and it is proposed that the cholesterol esters are 
kept locally in the nerve until cholesterol is required to form 
the myelin membranes. It is plausible to think that apo A-I 
might associate with lipid particles containing a high amount 
of cholesterol ester and deliver these to their required site. 
The transport of these lipoprotein particles through the my- 
elin could occur via the Schmidt-Lantermann clefts, which 
were once proposed to facilitate the transfer of components 
through the myelin sheath (Singer and Bryant,  1969). 
The transfer of lipids to the myelin sheath has also been 
observed from the axon (Droz et al.,  1978).  Labeled lipids 
from the axon were observed to appear rapidly in the inner 
myelin sheath as well as at the outer Schwann cell cytoplasm. 
This transfer of lipids from neural to glial cell is proposed 
to be a mechanism for the maintenance of the glial cell my- 
elin sheath. The transfer of lipids has been proposed to occur 
by phospholipid transport proteins (Droz et al.,  1978).  An- 
other possibility is that the exchange or transfer of lipids is 
mediated by apo A-I-containing lipoproteins. 
The uptake of cholesterol into the sciatic nerve from the 
blood has  also  been  observed (Rawlins,  1973).  One  can 
visualize the delivery of cholesterol from circulating plasma 
lipoprotein particles to apo A-I-containing lipoproteins of 
the sciatic nerve. 
One intriguing possibility is that active transcription and 
translation of the apo A-I gene in the developing avian nerve 
reflect a role unrelated to inter- or intracellular lipid trans- 
port, but indicate a possible involvement in the differentia- 
tion of Schwann cells. Our demonstration of the secretion of 
apo A-I by the sciatic nerve and the possible presence of this 
The Journal of Cell Biology, Volume  109, 1989  1254 antigen  in the  extracellular  matrix  supports  this  role.  We 
speculate  (following the  suggestion  of Mahley,  1988)  that 
apo A-I in the chick sciatic nerve may interact  with mole- 
cules in the extracellular matrix and may participate  or mod- 
ify cell-matrix or growth factor-matrix interactions. 
The results  of our investigations also raise a number of 
questions about the exact nature of the lipoprotein particles, 
the possible role of lipoprotein receptors, the identity of the 
cell types that synthesize and secrete apo A-I, and the regula- 
tion of the expression of the apo A-I gene in the chick sciatic 
nerve.  Further  lipoprotein  fractionation  and characteriza- 
tion, quantitative  metabolic experiments with organ or cell 
culture,  immunocytochemical  electronmicroscopy,  and  in 
situ hybridization techniques should provide answers to these 
and  other questions.  Currently  these  experiments  are  ac- 
tively being pursued in our laboratories. 
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